Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
在 313 例炎症性肠病患者中，从原研英夫利昔单抗换用生物类似药 CT-P13
期刊:
影响因子:
doi:10.1177/1756284818801244
Bergqvist, Viktoria; Kadivar, Mohammad; Molin, Daniel; Angelison, Leif; Hammarlund, Per; Olin, Marie; Torp, Jörgen; Grip, Olof; Nilson, Stefan; Hertervig, Erik; Lillienau, Jan; Marsal, Jan
